Hand holding the newspaper resting on a table with a cup of coffee

Newsroom

Taxonomy Icon
New Study Makes Important Step Toward Treatment Of Deadly Brain Cancer
  • November 27, 2018
A new Ivy Brain Tumor Center study finds that recently-approved drug ribociclib may be an important part of treatment for glioblastoma, one of the deadliest cancers in the world.
Taxonomy Icon
Ivy Brain Tumor Center to Study Treatments for Brain Malignancies
  • November 25, 2018
  • Source: The ASCO Post
The Ben and Catherine Ivy Foundation, in partnership with the Barrow Neurological Institute in Phoenix, has awarded a $50 million grant to establish a new translational science program focusing on early-phase, pharmacodynamic- and pharmacokinetic-driven clinical trials for aggressive brain tumors.
Taxonomy Icon
New brain tumor trials are on the fast track
  • November 8, 2018
  • Source: WNDU | 16 News Now
In the last 30 years, a brain tumor expert says median survival has only increased by a few months. Now, a new brain tumor center program is fast-tracking patients into new therapies.
Taxonomy Icon
Barrow receives major grant to find cure for deadliest brain cancer
  • September 10, 2018
  • Source: Phoenix Business Journal
Thanks to a $50 million grant, Barrow Neurological Institute will create a new center to focus on finding a cure and improving outcomes for the deadliest form of brain cancer.
Taxonomy Icon
$50M Barrow brain-tumor center will seek cures for ‘the most complex’ cancer
  • September 10, 2018
  • Source: Arizona Republic
With $50 million from a private foundation, Phoenix-based Barrow Neurological Institute announced Monday that it is opening a center to focus on improving brain-cancer outcomes through experimental clinical trials.
Taxonomy Icon
What is Glioblastoma? The brain cancer that killed McCain is hard to treat
  • August 26, 2018
  • Source: WKYC Studios
Barrow Neurological Institute, has launched a “phase zero” study that aims to rapidly test drugs on patients whose brain cancer tumors have returned after standard treatment.